(Q45929326)

17 December 2017

title

The role of peroxisome proliferator-activated receptor gamma in blood pressure regulation. (English)

1 reference

17 December 2017

author name string

Milton Hamblin

1

1 reference

17 December 2017

Lin Chang

2

1 reference

17 December 2017

Jifeng Zhang

3

1 reference

17 December 2017

Y Eugene Chen

4

1 reference

17 December 2017

publication date

1 August 2009

1 reference

17 December 2017

Current Hypertension Reports

published in

1 reference

17 December 2017

volume

11

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

239-245

1 reference

17 December 2017

Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats.

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-009-0041-6

Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-009-0041-6

Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk

21 January 2018

1 reference

12 December 2020

Generation of an adult smooth muscle cell-targeted Cre recombinase mouse model

1 reference

12 December 2020

PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice

1 reference

12 December 2020

Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet.

1 reference

12 December 2020

PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice

1 reference

12 December 2020

Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice

1 reference

12 December 2020

PPARgamma in endothelial cells influences high fat diet-induced hypertension

1 reference

12 December 2020

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

12 December 2020

A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome

1 reference

12 December 2020

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

1 reference

12 December 2020

Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension

1 reference

12 December 2020

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1 reference

12 December 2020

A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms.

1 reference

12 December 2020

PPAR-gamma regulates osteoclastogenesis in mice

1 reference

12 December 2020

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

12 December 2020

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

12 December 2020

A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy

1 reference

12 December 2020

Cardiac peroxisome proliferator-activated receptor γ is essential in protecting cardiomyocytes from oxidative damage

1 reference

12 December 2020

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

12 December 2020

Mechanisms of vasorelaxation induced by troglitazone, a novel antidiabetic drug, in the porcine coronary artery

1 reference

12 December 2020

Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma

1 reference

12 December 2020

Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect

1 reference

12 December 2020

Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension.

1 reference

12 December 2020

PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma and metabolic disease.

1 reference

12 December 2020

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

12 December 2020

Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality

1 reference

12 December 2020

Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells

1 reference

12 December 2020

Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling.

1 reference

12 December 2020

International union of pharmacology. XXIII. The angiotensin II receptors

1 reference

12 December 2020

Vascular smooth muscle cell-selective peroxisome proliferator-activated receptor-gamma deletion leads to hypotension

1 reference

12 December 2020

A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes

1 reference

12 December 2020

An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension

1 reference

12 December 2020

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

12 December 2020

Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences

1 reference

12 December 2020

Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand

1 reference

12 December 2020

Circadian variation of blood pressure and the vascular response to asynchronous stress

1 reference

12 December 2020

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

12 December 2020

Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1

1 reference

12 December 2020

Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats

1 reference

12 December 2020

Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone

1 reference

12 December 2020

Medical significance of peroxisome proliferator-activated receptors.

1 reference

12 December 2020

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Actions of peroxisome proliferator-activated receptors-gamma agonists explaining a possible blood pressure-lowering effect

1 reference

12 December 2020

Impaired expression of PPAR gamma protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gammaPro12Ala polymorphism and the association with blood pressure in type 2 diabetes: skaraborg hypertension and diabetes project.

1 reference

12 December 2020

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

12 December 2020

10.1007/S11906-009-0041-6

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1018854408

0 references

1 reference

17 December 2017